Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnostic tests for lung cancer

E S Edell1

  • 1Mayo Clinic, Rochester, MN 55905, USA.

Current Opinion in Pulmonary Medicine
|July 1, 1997
PubMed
Summary
This summary is machine-generated.

New diagnostic technologies offer hope for reducing lung cancer mortality. Early detection of premalignant changes and peripheral lung nodules through advanced imaging and biomarkers may significantly impact survival rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Evaluating physician concordance in interpretation of tracheobronchomalacia diagnosis and phenotyping using dynamic expiratory chest computed tomography.

Scientific reports·2025
Same author

Evaluating physician concordance in interpretation of tracheobronchomalacia diagnosis and phenotyping using dynamic expiratory chest computed tomography.

Scientific reports·2025
Same author

High-grade lesion: What does it tell us?

Thorax·2006
Same author

Tracheobronchial foreign bodies.

Chest surgery clinics of North America·2002
Same author

External-beam radiation therapy in the treatment of diffuse tracheobronchial amyloidosis.

Mayo Clinic proceedings·2001
Same author

Strategic performance management: development of a performance measurement system at the Mayo Clinic.

Journal of healthcare management / American College of Healthcare Executives·2000

Area of Science:

  • Oncology
  • Pulmonology
  • Radiology

Background:

  • Bronchogenic carcinoma remains the leading cause of cancer death in the U.S.
  • Traditional diagnostic methods like chest X-rays and sputum cytology have shown limited impact on lung cancer mortality over the past two decades.
  • Identifying risk factors such as obstructive lung disease and family history is crucial for targeted prevention strategies.

Purpose of the Study:

  • To review emerging diagnostic technologies for lung cancer.
  • To highlight advancements that may improve early detection and alter mortality rates.

Main Methods:

  • Review of recent articles on novel diagnostic technologies for lung cancer.
  • Focus on biological markers in sputum for detecting premalignant changes.

Related Experiment Videos

  • Evaluation of advanced radiologic imaging techniques, including CT scans and PET scans, for identifying peripheral lung nodules.

    • Main Results:

    • Identification of biological markers in sputum specimens shows potential for early detection of premalignant changes.
    • Advanced imaging like CT scans with contrast and PET scans may improve the early detection of peripheral lung nodules.
    • New technologies present opportunities to significantly impact overall lung cancer mortality.

    Conclusions:

    • Development and implementation of new diagnostic technologies are essential for reducing lung cancer mortality.
    • Early detection of premalignant changes and peripheral nodules through advanced methods holds promise for improved patient outcomes.
    • Continued research into novel diagnostic approaches is critical for combating lung cancer.